The Power Of Artificial Intelligence And Route Scouting To Navigate API Complexity

As active pharmaceutical ingredients (APIs) continue to grow more complex, process chemists must reconcile more elaborate synthetic pathways with a continued push to reach the clinic rapidly. To achieve efficient API manufacturing, drug sponsors are looking for fast and effective strategies to fulfill raw material needs and avoid supply chain hiccups. In a recent webinar hosted by Lonza Small Molecules and Elsevier Life Sciences, Dr. Ryan Littich, Head of Advanced Chemistry Technologies, Global R&D, Lonza; and Dr. Juergen Swienty-Busch, Director of Product Management for Chemistry, Elsevier Information Systems, discussed the impact of leveraging predictive retrosynthesis route design and a custom, building block library to yield time and cost savings for sponsors developing complex APIs. In the post-webinar Q&A, they tackled questions on the impact of artificial intelligence (AI) on route design, cost-effective modifications, and overall timelines for route scouting. Download the full Q&A to read their insights and advice.